Author:
Gorovets Daniel,Wibmer Andreas G.,Moore Assaf,Lobaugh Stephanie,Zhang Zhigang,Kollmeier Marisa,McBride Sean,Zelefsky Michael J.
Subject
Urology,Radiology, Nuclear Medicine and imaging,Oncology,Surgery
Reference31 articles.
1. Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial;Widmark;Lancet Lond Engl,2019
2. Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial;Brand;Lancet Oncol,2019
3. Long-term Outcomes of Stereotactic Body Radiotherapy for Low-Risk and Intermediate-Risk Prostate Cancer;Kishan;JAMA Netw Open,2019
4. Stereotactic Body Radiation Therapy for Localized Prostate Cancer: A Systematic Review and Meta-Analysis of Over 6,000 Patients Treated On Prospective Studies;Jackson;Int J Radiat Oncol Biol Phys,2019
5. Early Tolerance and Tumor Control Outcomes with High-dose Ultrahypofractionated Radiation Therapy for Prostate Cancer;Zelefsky;Eur Urol Oncol,2019
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献